Guidelines - NeLM

Homepage

Search the NeLM

Medicines A-Z

Find key information about medicines by name (prototype)

Browse by Categories:

Browse by NeLM area:

Evidence > Guidelines

Medication Safety
Complementary Medicine
Medicines Q & A
Drug Monitoring
(Reviews for Individual Funding Requests (IFRs))

660 library items in Guidelines

Summaries of clinical guidelines with implications for medicine use from nationally recognized bodies such as CKS, NICE and SIGN.

Filter results by:

Date Published

Category

Results filtered by:

Area

Guidelines (remove)

Sort by: Display summary:

Results 1 - 10 of 660

Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next

1.

NICE issues guidelines on diagnosis and management of the epilepsies in adults and children in primary and secondary care

Source: NICE,
Date published: 26/01/2012

Category:

4.8 Antiepileptic drugs | Clinical guidelines | Epilepsy | National Institute of Clinical Excellence (NICE) | Paediatrics

NeLM Area:

Evidence > Guidelines

Press release

Link to guidance
2.

NICE issues final guidance on apixaban for the prevention of VTE after total hip or knee replacement in adults

Source: NICE,
Date published: 25/01/2012

Category:

2.8.2 Oral anticoagulants | Clinical guidelines | National Institute of Clinical Excellence (NICE) | Venous Thromboembolism

NeLM Area:

Evidence > Guidelines

Link (TA 245)
3.

NICE issues final guidance on rituximab for follicular lymphoma

Source: NICE,
Date published: 25/01/2012

Category:

8.2.4 Other immunomodulating drugs | Clinical guidelines | Lymphoma | National Institute of Clinical Excellence (NICE)

NeLM Area:

Evidence > Guidelines

Link (TA 243)
4.

NICE issues final guidance on cetuximab, bevacizumab and panitumumab for metastatic colorectal cancer (second-line)

Source: NICE,
Date published: 25/01/2012

Category:

8.1.5 Other antineoplastic drugs | Cancer: gastroenterological | Clinical guidelines | National Institute of Clinical Excellence (NICE)

NeLM Area:

Evidence > Guidelines

Link (TA 242)
5.

NICE issues final guidance on roflumilast for severe COPD

Source: NICE,
Date published: 25/01/2012

Category:

3.3.3 Phosphodiesterase type-4 inhibitors | Chronic Obstructive Airways Disease | Clinical guidelines | National Institute of Clinical Excellence (NICE)

NeLM Area:

Evidence > Guidelines

Link (TA 244)
6.

NICE issues final guidance on dasatinib, high-dose imatinib and nilotinib for chronic myeloid leukaemia (CML)

Source: NICE,
Date published: 13/01/2012

Category:

8.1.5 Other antineoplastic drugs | Clinical guidelines | Leukaemia | National Institute of Clinical Excellence (NICE)

NeLM Area:

Evidence > Guidelines

Link

NICE TA 70
7.

NICE issues clinical guideline on the diagnosis and management of the epilepsy in adults and children in primary and secondary care

Source: NICE,
Date published: 12/01/2012

Category:

4.8.1 Control of epilepsy | Clinical guidelines | Epilepsy | National Institute of Clinical Excellence (NICE)

NeLM Area:

Evidence > Guidelines

Link to guidance CG137
8.

NICE clinical guideline and quality standard on experience of care for adults using NHS mental health services

Source: NICE Clinical Guideline,
Date published: 21/12/2011

Category:

Clinical guidelines | Mental Health | National Institute of Clinical Excellence (NICE)

NeLM Area:

Evidence > Guidelines

Link
9.

SIGN updates guideline on diagnosis and management of colorectal cancer

Source: SIGN,
Date published: 15/12/2011

Category:

8.1 Cytotoxic drugs | Cancer: gastroenterological | Clinical guidelines

NeLM Area:

Evidence > Guidelines

Link
10.

NICE unable to recommend use of panitumumab in combination with chemotherapy for metastatic colorectal cancer due to non-submission

Source: NICE,
Date published: 14/12/2011

Category:

8.1.5 Other antineoplastic drugs | Cancer: gastroenterological | Clinical guidelines | National Institute of Clinical Excellence (NICE)

NeLM Area:

Evidence > Guidelines

NICE TA240

Results 1 - 10 of 660

Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next